OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Outcomes of COVID ‐19 in multiple myeloma patients treated with daratumumab
Dian Jin, Jingsong He, Wenjun Wu, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 237-246
Open Access | Times Cited: 7
Dian Jin, Jingsong He, Wenjun Wu, et al.
Cancer Science (2023) Vol. 115, Iss. 1, pp. 237-246
Open Access | Times Cited: 7
Showing 7 citing articles:
Elevated LIF and JAK-STAT activation drive severe COVID-19 in myeloma patients receiving the BCMA-CD3 bispecific antibody Elranatamab
Ziping Li, Fujing Zhang, Xianghong Jin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ziping Li, Fujing Zhang, Xianghong Jin, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Clinical characteristics and outcomes of BCMA-targeted CAR-T cell recipients with COVID-19 during the Omicron wave: a retrospective study
Haiqiong Zheng, Han Shi, Yijin Chen, et al.
Bone Marrow Transplantation (2025)
Open Access
Haiqiong Zheng, Han Shi, Yijin Chen, et al.
Bone Marrow Transplantation (2025)
Open Access
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation
Marco Falcone, Giusy Tiseo, G. Marchetti, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-8
Closed Access | Times Cited: 1
Marco Falcone, Giusy Tiseo, G. Marchetti, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-8
Closed Access | Times Cited: 1
Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis
Sultan Mahmud, Md Faruk Hossain, Abdul Muyeed, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308463-e0308463
Open Access | Times Cited: 1
Sultan Mahmud, Md Faruk Hossain, Abdul Muyeed, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308463-e0308463
Open Access | Times Cited: 1
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR)
Naomi Aoki, Pin-Yen Chen, Wenming Chen, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access
Naomi Aoki, Pin-Yen Chen, Wenming Chen, et al.
BMC Medical Research Methodology (2024) Vol. 24, Iss. 1
Open Access
